Citalopram Supplier-Buyer Network — Trade Flow Analysis

Name: Citalopram Supplier-Buyer Trade Network Dataset — 257+ Indian Exporters, 18+ Importers, 101+ Countries (DGFT 2022–2026)
Creator: TransData Nexus
License: https://transdatanexus.com/terms
Keywords: Citalopram supplier network, Citalopram buyers, pharmaceutical export India, Citalopram trade data

TransData Nexus

Citalopram

India Pharmaceutical Trade Intelligence

$254.5M257 Suppliers101 CountriesHS 30049099

ExportsIndia → MOROCCO31.6%India → UNITED STATES28.8%

ImportsCANADA → India$5.3M UNITED STATES → India$24.9K

#1 Supplier: MEDISPRAY LABORATORIES #1 Buyer: CIPLA MAROC

Who Supplies Citalopram? Top Manufacturers & Buyers 2026 — MEDISPRAY LABORATORIES PRIVATE LIMITED Leads | TransData Nexus | TransData Nexus

1MEDISPRAY LABORATORIES PRIVATE LIMITED

MEDISPRAY LABORATORIES PRIVATE LIMITED is the first-largest Citalopram exporter from India, with a market share of 30.4% and a total export value of $77.3M across 77 shipments. Their average shipment value of $1.0M is above the market average of $34.5K, suggesting premium or bulk contract pricing.

MEDISPRAY LABORATORIES PRIVATE LIMITED serves 3 named buyers in our database. CIPLA MAROC is the dominant customer, accounting for 99.5% of this supplier's tracked business. Top customers include:

• CIPLA MAROC — $77.0M across 77 shipments (99.5% of this supplier's total exports)

• CIPLA MAROC ANGLE RU — $214.9K across 0 shipments (0.3% of this supplier's total exports)

• CIPLA MAROC — $135.2K across 0 shipments (0.2% of this supplier's total exports)

Key Insight: MEDISPRAY LABORATORIES PRIVATE LIMITED's per-shipment value of $1.0M is 2809% above the market average of $34.5K, consistent with large-order contracts or value-added formulations.

2TORRENT PHARMACEUTICALS LTD

TORRENT PHARMACEUTICALS LTD is the second-largest Citalopram exporter from India, with a market share of 5.6% and a total export value of $14.4M across 345 shipments. Their average shipment value of $41.6K is above the market average of $34.5K, suggesting premium or bulk contract pricing.

TORRENT PHARMACEUTICALS LTD serves 5 named buyers in our database. TORRENT PHARMA INC is the dominant customer, accounting for 77.5% of this supplier's tracked business. Top customers include:

• TORRENT PHARMA INC — $11.1M across 267 shipments (77.5% of this supplier's total exports)

• TORRENT PHARMA INC IMPORTER EIN 36-4547412 — $1.4M across 34 shipments (9.9% of this supplier's total exports)

• HEUMANN PHARMA GMBH — $806.5K across 19 shipments (5.6% of this supplier's total exports)

• DKSH MALAYSIA SDN BH — $526.1K across 13 shipments (3.7% of this supplier's total exports)

• TORRENT DO BRASIL LT — $471.4K across 11 shipments (3.3% of this supplier's total exports)

Key Insight: TORRENT PHARMACEUTICALS LTD's per-shipment value of $41.6K is 21% above the market average of $34.5K, consistent with large-order contracts or value-added formulations.

3MYLAN LABORATORIES LIMITED

MYLAN LABORATORIES LIMITED is the third-largest Citalopram exporter from India, with a market share of 5.2% and a total export value of $13.3M across 202 shipments. Their average shipment value of $65.8K is above the market average of $34.5K, suggesting premium or bulk contract pricing.

MYLAN LABORATORIES LIMITED serves 5 named buyers in our database. MYLAN PHARMACEUTICALS INC, is the dominant customer, accounting for 82.9% of this supplier's tracked business. Top customers include:

• MYLAN PHARMACEUTICALS INC, — $11.0M across 168 shipments (82.9% of this supplier's total exports)

• MYLAN PHARMACEUTICALS INC, — $1.5M across 23 shipments (11.2% of this supplier's total exports)

• MYLAN HUNGARY KFT, — $287.9K across 4 shipments (2.2% of this supplier's total exports)

• MYLAN PHARMACEUTICALS INC, — $276.0K across 4 shipments (2.1% of this supplier's total exports)

• MYLAN HUNGARY KFT, — $219.7K across 3 shipments (1.7% of this supplier's total exports)

Key Insight: MYLAN LABORATORIES LIMITED's per-shipment value of $65.8K is 91% above the market average of $34.5K, consistent with large-order contracts or value-added formulations.

4SUN PHARMACEUTICAL INDUSTRIES LIMITED

SUN PHARMACEUTICAL INDUSTRIES LIMITED is the fourth-largest Citalopram exporter from India, with a market share of 4.5% and a total export value of $11.5M across 463 shipments. Their average shipment value of $24.7K is below the market average of $34.5K, reflecting a high-volume, competitive pricing strategy.

SUN PHARMACEUTICAL INDUSTRIES LIMITED serves 5 named buyers in our database. YUSEN LOGISTICS BENELUX BELGIUM is the dominant customer, accounting for 76.9% of this supplier's tracked business. Top customers include:

• YUSEN LOGISTICS BENELUX BELGIUM — $8.8M across 356 shipments (76.9% of this supplier's total exports)

• RANBAXY (THAILAND) C — $855.6K across 35 shipments (7.5% of this supplier's total exports)

• M S SUN PHARMACEUTIC — $770.0K across 31 shipments (6.7% of this supplier's total exports)

• YUSEN LOGISTICS BENELUX BELGIUM — $518.7K across 21 shipments (4.5% of this supplier's total exports)

• M/S. RANBAXY FARMACEUTICA LTDA : — $507.2K across 20 shipments (4.4% of this supplier's total exports)

Key Insight: SUN PHARMACEUTICAL INDUSTRIES LIMITED operates with high shipment frequency (463 shipments) at a per-shipment value of $24.7K, indicating a broad distribution network with many smaller, regular orders.

5AUROBINDO PHARMA LTD

AUROBINDO PHARMA LTD is the fifth-largest Citalopram exporter from India, with a market share of 4.2% and a total export value of $10.6M across 1.0K shipments. Their average shipment value of $10.2K is below the market average of $34.5K, reflecting a high-volume, competitive pricing strategy.

AUROBINDO PHARMA LTD serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:

• AUROLOGISTICS LLC AUROBINDO PHARM — $4.7M across 458 shipments (44.2% of this supplier's total exports)

• AUROLOGISTICS LLC AUROBINDO PHARM — $2.2M across 211 shipments (20.4% of this supplier's total exports)

• APL SWIFT SERVICES ( — $1.4M across 139 shipments (13.4% of this supplier's total exports)

• AUROLOGISTICS LLC — $1.2M across 121 shipments (11.7% of this supplier's total exports)

• AURO PHARMA INC — $1.1M across 106 shipments (10.3% of this supplier's total exports)

Key Insight: AUROBINDO PHARMA LTD operates with high shipment frequency (1.0K shipments) at a per-shipment value of $10.2K, indicating a broad distribution network with many smaller, regular orders.

6AUROBINDO PHARMA LIMITED

AUROBINDO PHARMA LIMITED is the fifth-largest Citalopram exporter from India, with a market share of 3.1% and a total export value of $7.9M across 420 shipments. Their average shipment value of $18.9K is below the market average of $34.5K, reflecting a high-volume, competitive pricing strategy.

AUROBINDO PHARMA LIMITED serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:

• AUROLOGISTICS LLC AUROBINDO PHARM — $3.9M across 204 shipments (48.6% of this supplier's total exports)

• AUROLOGISTICS LLC — $2.0M across 104 shipments (24.8% of this supplier's total exports)

• AUROLOGISTICS LLC AUROBINDO PHARM — $717.3K across 38 shipments (9.1% of this supplier's total exports)

• ORION CORPORATION — $703.7K across 37 shipments (8.9% of this supplier's total exports)

• AURO PHARMA INC — $683.5K across 36 shipments (8.6% of this supplier's total exports)

Key Insight: AUROBINDO PHARMA LIMITED operates with high shipment frequency (420 shipments) at a per-shipment value of $18.9K, indicating a broad distribution network with many smaller, regular orders.

1Morocco

Morocco ranks as the first-largest destination for Citalopram imports from India, with a total trade value of $80.4M across 71 shipments — representing a 31.6% share of all Citalopram exports. The average shipment value of $1.1M is above the global average of $34.5K, indicating high-value procurement contracts or branded formulations. This market is served by 1 tracked buyer.

Named Citalopram importers in Morocco: CIPLA MAROC is the largest buyer, accounting for 96.0% ($77.2M) of this market's total imports.

• CIPLA MAROC — $77.2M (96.0% of Morocco's total)

Key Insight: Morocco's per-shipment average of $1.1M (3180% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.

Morocco is a key market for Citalopram imports from India.

Primary Market

Secondary Market

2United States

United States ranks as the second-largest destination for Citalopram imports from India, with a total trade value of $73.4M across 758 shipments — representing a 28.8% share of all Citalopram exports. The average shipment value of $96.8K is above the global average of $34.5K, indicating high-value procurement contracts or branded formulations. This market is served by 11 tracked buyers.

Named Citalopram importers in United States: TORRENT PHARMA INC is the largest buyer, accounting for 20.7% ($15.2M) of this market's total imports.

• TORRENT PHARMA INC — $15.2M (20.7% of United States's total)

• MYLAN PHARMACEUTICALS INC — $11.9M (16.2% of United States's total)

• AUROLOGISTICS LLC (AUROBINDO PHARMA — $5.4M (7.4% of United States's total)

Key Insight: United States's per-shipment average of $96.8K (180% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.

United States is a key market for Citalopram imports from India.

Primary Market

Secondary Market

3Belgium

Belgium ranks as the third-largest destination for Citalopram imports from India, with a total trade value of $12.0M across 179 shipments — representing a 4.7% share of all Citalopram exports. The average shipment value of $67.2K is above the global average of $34.5K, indicating high-value procurement contracts or branded formulations. This market is served by 1 tracked buyer.

Named Citalopram importers in Belgium: YUSEN LOGISTICS BENELUX BELGIUM is the largest buyer, accounting for 79.9% ($9.6M) of this market's total imports.

• YUSEN LOGISTICS BENELUX BELGIUM — $9.6M (79.9% of Belgium's total)

Key Insight: Belgium's per-shipment average of $67.2K (95% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.

Belgium is a key market for Citalopram imports from India.

Primary Market

Secondary Market

4Brazil

Brazil ranks as the fourth-largest destination for Citalopram imports from India, with a total trade value of $10.7M across 91 shipments — representing a 4.2% share of all Citalopram exports. The average shipment value of $117.7K is above the global average of $34.5K, indicating high-value procurement contracts or branded formulations. This market is served by 2 tracked buyers.

Named Citalopram importers in Brazil: M/S. RANBAXY FARMACEUTICA LTDA : is the largest buyer, accounting for 41.6% ($4.5M) of this market's total imports.

• M/S. RANBAXY FARMACEUTICA LTDA : — $4.5M (41.6% of Brazil's total)

• SANDOZ DO BRASIL IND FARMACEUTICA — $1.8M (16.6% of Brazil's total)

Key Insight: Brazil's per-shipment average of $117.7K (241% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.

Brazil is a key market for Citalopram imports from India.

Primary Market

Secondary Market

5Canada

Canada ranks as the fifth-largest destination for Citalopram imports from India, with a total trade value of $10.1M across 0 shipments — representing a 4.0% share of all Citalopram exports. The average shipment value of $10.1M is above the global average of $34.5K, indicating high-value procurement contracts or branded formulations.

Key Insight: Canada's per-shipment average of $10.1M (29278% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.

Canada is a key market for Citalopram imports from India.

Primary Market

Secondary Market

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Network Construction: Supplier-to-buyer trade relationships constructed from verified shipment pairs in Indian Customs (DGFT) records for Citalopram.
2.Flow Mapping: 257 Indian manufacturers mapped to their international buyer networks using consignee name normalization.
3.Value Aggregation: Trade value per supplier-buyer link aggregated from 7,372 individual shipment records. Values are FOB in USD.
4.Geographic Clustering: Buyer networks clustered across 101 destination countries to identify geographic concentration patterns.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

7,372 Verified Shipments

257 manufacturers in network

Expert-Reviewed

By pharmaceutical trade specialists

Citalopram

Citalopram

Who Supplies Citalopram? Top Manufacturers & Their Global Buyers

🏭 Market Analysis: Top Suppliers & Customer Networks

Citalopram — Export Intelligence Video

Market Intelligence

Official References & Regulatory Resources

Who Supplies Citalopram? Top Manufacturers & Their Buyers

Supplier-Customer Network Analysis

Citalopram Supplier Network — Key Market Intelligence

Market Analysis: Top Suppliers & Their Customer Networks

1MEDISPRAY LABORATORIES PRIVATE LIMITED

2TORRENT PHARMACEUTICALS LTD

3MYLAN LABORATORIES LIMITED

4SUN PHARMACEUTICAL INDUSTRIES LIMITED

5AUROBINDO PHARMA LTD

6AUROBINDO PHARMA LIMITED

From Indian Factories to Global Pharmacies — How Citalopram Flows

🌍 Market Analysis: Top Importing Countries & Importers

Where Does Citalopram Go? Top Importing Countries & Their Buyers

Geographic Market Flow Analysis

Market Analysis: Top Importing Countries & Their Importers

1Morocco

2United States

3Belgium

4Brazil

5Canada

People Also Ask — Citalopram Supplier & Trade Network

Citalopram Trade Network — Key Takeaways

Network Overview

Supplier Network

Country Network

Network Insights

Related Analysis

Network Intelligence

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology